Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Kirsten M Boughan"'
Autor:
Adam S. Zayac, Andrew M. Evens, Alexey Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie, Catherine Wei, Seo-Hyun Kim, Seema Naik, Suchitra Sundaram, Nishitha Reddy, Umar Farooq, Vaishalee P. Kenkre, Narendranath Epperla, Kristie A. Blum, Nadia Khan, Daulath Singh, Juan P. Alderuccio, Amandeep Godara, Maryam Sarraf Yazdy, Catherine Diefenbach, Emma Rabinovich, Gaurav Varma, Reem Karmali, Yusra Shao, Asaad Trabolsi, Madelyn Burkart, Peter Martin, Sarah Stettner, Ayushi Chauhan, Yun Kyong Choi, Allandria Straker-Edwards, Andreas Klein, Michael C. Churnetski, Kirsten M. Boughan, Stephanie Berg, Bradley M. Haverkos, Victor M. Orellana-Noia, Christopher D'Angelo, David A. Bond, Seth M. Maliske, Ryan Vaca, Gabriella Magarelli, Amy Sperling, Max J. Gordon, Kevin A. David, Malvi Savani, Paolo Caimi, Manali Kamdar, Matthew A Lunning, Neil Palmisiano, Parameswaran Venugopal, Craig A. Portell, Veronika Bachanova, Tycel Phillips, Izidore S. Lossos, Adam J. Olszewski
Publikováno v:
Haematologica, Vol 106, Iss 7 (2021)
Central nervous system (CNS) involvement in Burkitt lymphoma (BL) poses a major therapeutic challenge, and the relative ability of contemporary regimens to treat CNS involvement remains uncertain. We described prognostic significance of CNS involveme
Externí odkaz:
https://doaj.org/article/7ae0d22933a943c387290b9e2d6a94f3
Autor:
Paolo F Caimi, Martina Di Trani, Armin Ghobadi, Jane Reese, Benjamin Tomlinson, Folashade Otegbeye, Kirsten M Boughan, Molly Gallogly, Leland Metheny, Brenda W. Cooper, Boro Dropulic, Marcos J.G. de Lima, Carmelo Carlo-Stella
Publikováno v:
Blood. 140:7457-7459
Autor:
Narendranath Epperla, Nicolas Martinez-Calle, Veronika Bachanova, David Peace, Seo-Hyun Kim, Maryam Sarraf Yazdy, Andreas K. Klein, Andrew M. Evens, Neil Palmisiano, Scott E. Smith, Catherine Zhu, Manali Kamdar, Adam Zayac, Izidore S. Lossos, Catherine Diefenbach, Nadia Khan, Elizabeth H Phillips, Matthew A. Lunning, Alessia Dalla Pria, Knut B. Smeland, Chan Yoon Cheah, Adam J. Olszewski, Peter Martin, Anna Santarsieri, Kirsten M Boughan, Umar Farooq, Alexey V. Danilov, Graham P. Collins, Tycel Phillips, Reem Karmali, Alina S. Gerrie, Silvia Montoto, Stephen D. Smith, Shireen Kassam, Kevin A. David, Mark Bower, Deepa Jagadeesh, Tarec Christoffer El-Galaly, Kate Cwynarski, Suchitra Sundaram, Xiao Yin Zhang, Vaishalee P. Kenkre, Fredrik Ellin, Tatyana Feldman, Lasse Hjort Jakobsen, Craig A. Portell, Seema Naik, Nishitha Reddy, Kristie A. Blum
Publikováno v:
J Clin Oncol
Olszewski, A J, Jakobsen, L H, Collins, G P, Cwynarski, K, Bachanova, V, Blum, K A, Boughan, K M, Bower, M, Dalla Pria, A, Danilov, A, David, K A, Diefenbach, C, Ellin, F, Epperla, N, Farooq, U, Feldman, T A, Gerrie, A S, Jagadeesh, D, Kamdar, M, Karmali, R, Kassam, S, Kenkre, V P, Khan, N, Kim, S-H, Klein, A K, Lossos, I S, Lunning, M A, Martin, P, Martinez-Calle, N, Montoto, S, Naik, S, Palmisiano, N, Peace, D, Phillips, E H, Phillips, T J, Portell, C A, Reddy, N, Santarsieri, A, Sarraf Yazdy, M, Smeland, K B, Smith, S E, Smith, S D, Sundaram, S, Zayac, A S, Zhang, X-Y, Zhu, C, Cheah, C Y, El-Galaly, T C, Evens, A M & The Burkitt Lymphoma International Prognostic Index consortium 2021, ' Burkitt Lymphoma International Prognostic Index ', Journal of Clinical Oncology, vol. 39, no. 10, JCO2003288, pp. 1129-1138 . https://doi.org/10.1200/JCO.20.03288
Olszewski, A J, Jakobsen, L H, Collins, G P, Cwynarski, K, Bachanova, V, Blum, K A, Boughan, K M, Bower, M, Dalla Pria, A, Danilov, A, David, K A, Diefenbach, C, Ellin, F, Epperla, N, Farooq, U, Feldman, T A, Gerrie, A S, Jagadeesh, D, Kamdar, M, Karmali, R, Kassam, S, Kenkre, V P, Khan, N, Kim, S-H, Klein, A K, Lossos, I S, Lunning, M A, Martin, P, Martinez-Calle, N, Montoto, S, Naik, S, Palmisiano, N, Peace, D, Phillips, E H, Phillips, T J, Portell, C A, Reddy, N, Santarsieri, A, Sarraf Yazdy, M, Smeland, K B, Smith, S E, Smith, S D, Sundaram, S, Zayac, A S, Zhang, X-Y, Zhu, C, Cheah, C Y, El-Galaly, T C, Evens, A M & The Burkitt Lymphoma International Prognostic Index consortium 2021, ' Burkitt Lymphoma International Prognostic Index ', Journal of Clinical Oncology, vol. 39, no. 10, JCO2003288, pp. 1129-1138 . https://doi.org/10.1200/JCO.20.03288
PURPOSE Burkitt lymphoma (BL) has unique biology and clinical course but lacks a standardized prognostic model. We developed and validated a novel prognostic index specific for BL to aid risk stratification, interpretation of clinical trials, and tar
Autor:
Craig A. Portell, Seo-Hyun Kim, Catherine Wei, Neil Palmisiano, Catherine Diefenbach, Manali Kamdar, Madelyn Burkart, Nadia Khan, Seth M. Maliske, Izidore S. Lossos, Andreas K. Klein, Paolo Caimi, Narendranath Epperla, Amandeep Godara, Alexey V. Danilov, Victor M. Orellana-Noia, Max J. Gordon, Adam Zayac, Maryam Sarraf Yazdy, Allandria Straker-Edwards, Michael C. Churnetski, Ayushi Chauhan, Umar Farooq, Deepa Jagadeesh, Daulath Singh, Matthew A. Lunning, Suchitra Sundaram, Sarah Stettner, Kirsten M Boughan, Lori A. Leslie, Yusra F. Shao, Peter Martin, Amy Sperling, Stephen D. Smith, Reem Karmali, Bradley M. Haverkos, Parameswaran Venugopal, Veronika Bachanova, Tycel Phillips, Yun Kyong Choi, Malvi Savani, Seema Naik, Gaurav Varma, Vaishalee P. Kenkre, Gabriella Magarelli, Ryan Vaca, Asaad Trabolsi, Andrew M. Evens, Juan Pablo Alderuccio, Emma Rabinovich, Christopher D'Angelo, Nishitha Reddy, Adam J. Olszewski, Kristie A. Blum, Stephanie Berg, David A. Bond, Kevin A. David
Publikováno v:
Haematologica. 106:1932-1942
Central nervous system (CNS) involvement in Burkitt lymphoma (BL) poses a major therapeutic challenge, and the relative ability of contemporary regimens to treat CNS involvement remains uncertain. We described prognostic significance of CNS involveme
Autor:
Andreas K. Klein, Deepa Jagadeesh, Tarec Christoffer El-Galaly, Umar Farooq, Catherine Zhu, Nicolas Martinex-Calle, Craig A. Portell, Xiao-Yin Zhang, Adam J. Olszewski, Manali Kamdar, Andrew M. Evens, Neil Palmisiano, Tycel Phillips, Nadia Khan, Chan Yoon Cheah, Stephen D. Smith, Catherine Diefenbach, Vaishalee P. Kenkre, Reem Karmali, Silvia Montoto, Izidore S. Lossos, Graham P. Collins, Lasse Hjort Jakobsen, Alexey V. Danilov, Adam Zayac, Alina S. Gerrie, Matthew A. Lunning, Narendranath Epperla, Parameswaran Venugopal, Knut B. Smeland, Scott E. Smith, Kirsten M Boughan, Maryam Sarraf Yazdy, Suchitra Sundaram, Peter Martin, Kevin A. David, Anna Santarsieri, Alessia Dalla Pria, Nishitha Reddy, Seema Naik, Veronika Bachanova, Kristie A. Blum, David Peace, Kate Cwynarski, Elizabeth H Phillips, Shireen Kassam, Mark Bower, Tatyana Feldman, Fredrik Ellin
Publikováno v:
Blood. 136:46-49
Background. BL is a rare, high-grade B-cell lymphoma that is often studied in trials with small sample sizes. Historical definitions of "low-risk BL" vary between studies, use arbitrary cutoffs for lactate dehydrogenase (LDH), and identify a small fa
Autor:
Leland Metheny, Merle Kolk, Folashade Otegbeye, Kirsten M Boughan, Mouhamed Yazan Abou-Ismail, Paolo Caimi, Benjamin Tomlinson, Shufen Cao, Gayathri Ravi, Brenda W. Cooper, Marcos de Lima, Pingfu Fu, Molly Gallogly, Nicole Ferrari, Sowjanya Vuyyala
Publikováno v:
Bone Marrow Transplantation. 56:581-585
Allogeneic hematopoietic cell transplant (HCT) is a curative therapy for malignant and non-malignant blood diseases. Drug use may be associated with adverse outcomes. We performed a retrospective analysis to assess non-relapse mortality (NRM) and ove
Autor:
Philippe Armand, Kami J. Maddocks, Richard F. Ambinder, Weiyun Z. Ai, Rachel Rabinovitch, Cecil M. Benitez, Monika L. Metzger, Kirsten M Boughan, Alex F. Herrera, Celeste M. Bello, Matthew McKinney, Stuart Seropian, Patrick B. Johnston, Jennifer L. Burns, Richard T. Hoppe, Philip J. Bierman, Nadia Khan, Jane N. Winter, Bouthaina S. Dabaja, Karen C. Rosenspire, Carolyn Mulroney, Francisco J. Hernandez-Ilizaliturri, Jonathan McConathy, Leo I. Gordon, Joachim Yahalom, Jiayi Huang, Ranjana H. Advani, Randa Tao, Mark S. Kaminski, Vaishalee P. Kenkre, David S. Morgan, Ndiya Ogba, Ephraim P. Hochberg, Ryan C. Lynch
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:755-781
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN panel meets at least annually to review comments from reviewers within their institutions, exam
Autor:
Pingfu Fu, Benjamin Tomlinson, Shufen Cao, Kirsten M Boughan, Hillard M. Lazarus, Molly Gallogly, Sabarish Ayyappan, Leland Metheny, Gouri Dharmavaram, Marcos de Lima, Suchitra Sundaram, Paolo Caimi, Folashade Otegbeye, Brenda W. Cooper, Ehsan Malek
Publikováno v:
American Journal of Hematology. 95:918-926
Venous thromboembolic events (VTE) are a frequent complication of lymphoma. We conducted a retrospective analysis to compare VTE risk in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Subjects were randomly assigned to training a
Autor:
Nausheen Ahmed, Marcos de Lima, Sarah Kleinsorge Block, Folashade Otegbeye, Patricio Rojas, Jane Reese-Koc, Seema Patel, Boro Dropulic, Ashish Sharma, Kirsten M Boughan, Jennifer Schiavone, Paolo Caimi, Gabriela Pacheco Sanchez, Antoinette Hillian, M.A. Maschan, Rafick-Pierre Sekaly, Kayla Zamborsky
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
Anti-CD19 chimeric antigen receptor T (CAR-T) cells have demonstrated activity against relapsed/refractory lymphomas. Cytokine release syndrome (CRS) and immune effector cell – associated neurotoxicity syndrome (ICANS) are well-known complications.
Autor:
Jeries Kort, Molly Gallogly, Stanton L. Gerson, Marcos de Lima, Benjamin Tomlinson, Gi-Ming Wang, Ehsan Malek, James J. Driscoll, Curtis Tatsuoka, Kirsten M Boughan, Brenda W. Cooper, Paolo Caimi
Publikováno v:
Blood. 136:13-15
Multiple Myeloma (MM) is a cancer of terminally-differentiated plasma cells residing in the bone marrow. Myeloma cells frequently secrete monoclonal proteins that can be used to assess tumor volume and patient response to therapy. Monoclonal proteins